These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17508935)

  • 1. Medicinal chemistry and bioinformatics--current trends in drugs discovery with networks topological indices.
    González-Díaz H; Vilar S; Santana L; Uriarte E
    Curr Top Med Chem; 2007; 7(10):1015-29. PubMed ID: 17508935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issues.
    González-Díaz H; Romaris F; Duardo-Sanchez A; Pérez-Montoto LG; Prado-Prado F; Patlewicz G; Ubeira FM
    Curr Pharm Des; 2010; 16(24):2737-64. PubMed ID: 20642428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting antimicrobial drugs and targets with the MARCH-INSIDE approach.
    González-Díaz H; Prado-Prado F; Ubeira FM
    Curr Top Med Chem; 2008; 8(18):1676-90. PubMed ID: 19075774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From QSAR models of drugs to complex networks: state-of-art review and introduction of new Markov-spectral moments indices.
    Riera-Fernández P; Martín-Romalde R; Prado-Prado FJ; Escobar M; Munteanu CR; Concu R; Duardo-Sanchez A; González-Díaz H
    Curr Top Med Chem; 2012; 12(8):927-60. PubMed ID: 22352918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics, networks and connectivity indices.
    González-Díaz H; González-Díaz Y; Santana L; Ubeira FM; Uriarte E
    Proteomics; 2008 Feb; 8(4):750-78. PubMed ID: 18297652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From chemical graphs in computer-aided drug design to general Markov-Galvez indices of drug-target, proteome, drug-parasitic disease, technological, and social-legal networks.
    Riera-Fernández P; Munteanu CR; Dorado J; Martin-Romalde R; Duardo-Sanchez A; González-Diaz H
    Curr Comput Aided Drug Des; 2011 Dec; 7(4):315-37. PubMed ID: 22050683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical graphs, molecular matrices and topological indices in chemoinformatics and quantitative structure-activity relationships.
    Ivanciuc O
    Curr Comput Aided Drug Des; 2013 Jun; 9(2):153-63. PubMed ID: 23701000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fourth generation detour matrix-based topological indices for QSAR/QSPR - part-1: development and evaluation.
    Marwaha RK; Jangra H; Das KC; Bharatam PV; Madan AK
    Int J Comput Biol Drug Des; 2012; 5(3-4):335-60. PubMed ID: 23013658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of topological descriptors in QSAR and drug design: history and new trends.
    Gozalbes R; Doucet JP; Derouin F
    Curr Drug Targets Infect Disord; 2002 Mar; 2(1):93-102. PubMed ID: 12462157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of topological indices: computer-oriented approach.
    Skvortsova MI; Palyulin VA; Zefirov NS
    SAR QSAR Environ Res; 2009; 20(3-4):357-77. PubMed ID: 19544196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of MARCH-INSIDE & complex networks prediction of drugs: ADMET, anti-parasite activity, metabolizing enzymes and cardiotoxicity proteome biomarkers.
    González-Díaz H; Duardo-Sanchez A; Ubeira FM; Prado-Prado F; Pérez-Montoto LG; Concu R; Podda G; Shen B
    Curr Drug Metab; 2010 May; 11(4):379-406. PubMed ID: 20446904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detour matrix-based adjacent path eccentric distance sum indices for QSAR/QSPR. Part I: development and evaluation.
    Singh M; Bharatam PV; Madan AK
    Int J Comput Biol Drug Des; 2014; 7(4):295-318. PubMed ID: 25539844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates.
    Jónsdóttir SO; Jørgensen FS; Brunak S
    Bioinformatics; 2005 May; 21(10):2145-60. PubMed ID: 15713739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical Significance of Topological Indices: Importance in Drug Discovery Research.
    Bhatia KS; Gupta AK; Saxena AK
    Curr Top Med Chem; 2023; 23(29):2735-2742. PubMed ID: 37519204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances on the role of topological indices in drug discovery research.
    Estrada E; Uriarte E
    Curr Med Chem; 2001 Nov; 8(13):1573-88. PubMed ID: 11562286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational quantum chemistry and adaptive ligand modeling in mechanistic QSAR.
    De Benedetti PG; Fanelli F
    Drug Discov Today; 2010 Oct; 15(19-20):859-66. PubMed ID: 20709183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand efficiency indices as guideposts for drug discovery.
    Abad-Zapatero C; Metz JT
    Drug Discov Today; 2005 Apr; 10(7):464-9. PubMed ID: 15809192
    [No Abstract]   [Full Text] [Related]  

  • 18. Virtual screening and its integration with modern drug design technologies.
    Guido RV; Oliva G; Andricopulo AD
    Curr Med Chem; 2008; 15(1):37-46. PubMed ID: 18220761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superaugmented eccentric distance sum connectivity indices: novel highly discriminating topological descriptors for QSAR/QSPR.
    Gupta M; Gupta S; Dureja H; Madan AK
    Chem Biol Drug Des; 2012 Jan; 79(1):38-52. PubMed ID: 22014074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal complexes in medicinal chemistry: new vistas and challenges in drug design.
    Thompson KH; Orvig C
    Dalton Trans; 2006 Feb; (6):761-4. PubMed ID: 16437168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.